Expression of angiomodulin (tumor-derived adhesion factor/mac25) in invading tumor cells correlates with poor prognosis in human colorectal cancer
- 12 April 2001
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 95 (4) , 216-222
- https://doi.org/10.1002/1097-0215(20010720)95:4<216::aid-ijc1037>3.0.co;2-o
Abstract
Angiomodulin (tumor‐derived adhesion factor/mac25/insulin‐like growth factor binding protein‐7), a cell‐adhesive glycoprotein, is secreted by cancer cells and vascular endothelial cells. It may be involved in angiogenesis and modulation of the vascular functions necessary for tumor development. Although angiomodulin is expressed in colon cancer, there is limited information on it concerning cancer progression. In the present immunohistochemical study, we examined expression of angiomodulin in human colorectal cancer and its relationship with prognosis. A group of 89 surgically resected colorectal cancers was investigated immunohistochemically. In 37 cases (41.6%), angiomodulin was expressed in invading cancer cells. Early recurrence within 12 months after surgery was higher in patients with angiomodulin‐expressing cancer than in those without (p < 0.05). The Kaplan‐Meier life table revealed that patients with angiomodulin‐positive tumor cells had a shorter survival time than those with negative cells (p < 0.01). The prognosis of patients with Dukes' C and angiomodulin‐positive cells was apparently worse than that of patients with Dukes' D and angiomodulin‐negative cells. Multivariate analysis with logistic regression indicated that only angiomodulin expression in cancer cells, lymph node metastasis and age remained significant prognostic variables for survival (p < 0.05). Angiomodulin showed correlations with poor prognosis, indicating that it may be a useful prognostic marker in patients with colorectal cancer.Keywords
This publication has 18 references indexed in Scilit:
- Structural Requirements of Heparan Sulfate for the Binding to the Tumor-derived Adhesion Factor/Angiomodulin That Induces Cord-like Structures to ECV-304 Human Carcinoma CellsJournal of Biological Chemistry, 2000
- Exploring {2}-Metallacryptands and {2}-Metallacryptates with Quantum Chemical Methods - When (not only) Computer Chemists? Dreams Come TrueJournal of Molecular Modeling, 2000
- Identification of cell-binding site of angiomodulin (AGM/TAF/Mac25) that interacts with heparan sulfates on cell surfaceJournal of Cellular Biochemistry, 1999
- Down-regulation of T1A12/mac25, a novel insulin-like growth factor binding protein related gene, is associated with disease progression in breast carcinomasOncogene, 1998
- Inhibition of Insulin Receptor Activation by Insulin-like Growth Factor Binding ProteinsJournal of Biological Chemistry, 1997
- Insulin-like growth factors and their binding proteins in human colonocytes: preferential degradation of insulin-like growth factor binding protein 2 in colonic cancersBritish Journal of Cancer, 1997
- Cloning of the Functional Promoter for Human Insulin-Like Growth Factor Binding Protein-4 Gene: Endogenous Regulation1Endocrinology, 1997
- Specific accumulation of tumor-derived adhesion factor in tumor blood vessels and in capillary tube-like structures of cultured vascular endothelial cells.Proceedings of the National Academy of Sciences, 1996
- Proliferation and differentiation of a human colon cancer cell line (CaCo2) is associated with significant changes in the expression and secretion of insulin-like growth factor (IGF) IGF-II and IGF binding protein-4: role of IGF-II.Endocrinology, 1996
- Cell Adhesion Activity of a 30-kDa Major Secreted Protein from Human Bladder Carcinoma CellsBiochemical and Biophysical Research Communications, 1994